CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for May 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Option Exercise | M | 59.41 | 5,474 | 325,210 | 16,422 | |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Option Exercise | M | 40.40 | 5,502 | 222,281 | 0 | |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.93 | 203 | 18,865 | 16,549 | 16.8 K to 16.5 K (-1.21 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.92 | 500 | 46,460 | 16,752 | 17.3 K to 16.8 K (-2.90 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.91 | 604 | 56,118 | 17,252 | 17.9 K to 17.3 K (-3.38 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.91 | 100 | 9,291 | 17,856 | 18 K to 17.9 K (-0.56 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.90 | 197 | 18,301 | 17,956 | 18.2 K to 18 K (-1.09 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.90 | 402 | 37,344 | 18,153 | 18.6 K to 18.2 K (-2.17 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.89 | 1,103 | 102,458 | 18,555 | 19.7 K to 18.6 K (-5.61 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.89 | 121 | 11,239 | 19,658 | 19.8 K to 19.7 K (-0.61 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.88 | 500 | 46,440 | 19,779 | 20.3 K to 19.8 K (-2.47 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.87 | 300 | 27,861 | 20,279 | 20.6 K to 20.3 K (-1.46 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.86 | 193 | 17,922 | 20,579 | 20.8 K to 20.6 K (-0.93 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.86 | 300 | 27,857 | 20,772 | 21.1 K to 20.8 K (-1.42 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.85 | 290 | 26,927 | 21,072 | 21.4 K to 21.1 K (-1.36 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.84 | 1,000 | 92,840 | 21,362 | 22.4 K to 21.4 K (-4.47 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.83 | 200 | 18,566 | 22,362 | 22.6 K to 22.4 K (-0.89 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.82 | 889 | 82,517 | 22,562 | 23.5 K to 22.6 K (-3.79 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.81 | 205 | 19,026 | 23,451 | 23.7 K to 23.5 K (-0.87 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.81 | 166 | 15,406 | 23,656 | 23.8 K to 23.7 K (-0.70 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.80 | 1,669 | 154,883 | 23,822 | 25.5 K to 23.8 K (-6.55 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.80 | 400 | 37,118 | 25,491 | 25.9 K to 25.5 K (-1.54 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.79 | 100 | 9,279 | 25,891 | 26 K to 25.9 K (-0.38 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.79 | 134 | 12,433 | 25,991 | 26.1 K to 26 K (-0.51 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.78 | 712 | 66,059 | 26,125 | 26.8 K to 26.1 K (-2.65 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.77 | 188 | 17,441 | 26,837 | 27 K to 26.8 K (-0.70 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.75 | 300 | 27,825 | 27,025 | 27.3 K to 27 K (-1.10 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Sell | S | 92.74 | 200 | 18,548 | 27,325 | 27.5 K to 27.3 K (-0.73 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Buy | M | 59.41 | 5,474 | 325,210 | 22,023 | 16.5 K to 22 K (+33.08 %) |
May 31 2017 | CRL | CHARLES RIVER LABO ... | Molho Davide | Corporate Executive ... | Buy | M | 40.40 | 5,502 | 222,281 | 27,525 | 22 K to 27.5 K (+24.98 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Thompson Craig B. | Director | Grant | A | 0.00 | 793 | 0 | 14,929 | 14.1 K to 14.9 K (+5.61 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Thompson Craig B. | Director | Grant | A | 0.00 | 2,436 | 0 | 14,136 | 11.7 K to 14.1 K (+20.82 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 88.03 | 200 | 17,606 | 8,486 | 8.7 K to 8.5 K (-2.30 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 88.02 | 100 | 8,802 | 8,686 | 8.8 K to 8.7 K (-1.14 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Option Exercise | M | 70.29 | 3,140 | 220,711 | 0 | |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 88.01 | 100 | 8,801 | 8,786 | 8.9 K to 8.8 K (-1.13 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 88.01 | 100 | 8,801 | 8,886 | 9 K to 8.9 K (-1.11 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 88.00 | 600 | 52,800 | 8,986 | 9.6 K to 9 K (-6.26 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 88.00 | 210 | 18,479 | 9,586 | 9.8 K to 9.6 K (-2.14 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.99 | 301 | 26,485 | 9,796 | 10.1 K to 9.8 K (-2.98 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.99 | 200 | 17,597 | 10,097 | 10.3 K to 10.1 K (-1.94 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.98 | 337 | 29,649 | 10,297 | 10.6 K to 10.3 K (-3.17 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.97 | 590 | 51,902 | 10,634 | 11.2 K to 10.6 K (-5.26 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.97 | 122 | 10,732 | 11,224 | 11.3 K to 11.2 K (-1.08 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.96 | 278 | 24,453 | 11,346 | 11.6 K to 11.3 K (-2.39 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.96 | 200 | 17,591 | 11,624 | 11.8 K to 11.6 K (-1.69 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.95 | 290 | 25,506 | 11,824 | 12.1 K to 11.8 K (-2.39 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.94 | 400 | 35,176 | 12,114 | 12.5 K to 12.1 K (-3.20 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.93 | 200 | 17,586 | 12,514 | 12.7 K to 12.5 K (-1.57 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.93 | 300 | 26,378 | 12,714 | 13 K to 12.7 K (-2.31 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.92 | 200 | 17,584 | 13,014 | 13.2 K to 13 K (-1.51 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.92 | 10 | 879 | 13,214 | 13.2 K to 13.2 K (-0.08 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.91 | 100 | 8,791 | 13,224 | 13.3 K to 13.2 K (-0.75 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.89 | 400 | 35,156 | 13,324 | 13.7 K to 13.3 K (-2.91 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.89 | 300 | 26,366 | 13,724 | 14 K to 13.7 K (-2.14 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.88 | 400 | 35,152 | 14,024 | 14.4 K to 14 K (-2.77 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.87 | 300 | 26,361 | 14,424 | 14.7 K to 14.4 K (-2.04 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.85 | 200 | 17,569 | 14,724 | 14.9 K to 14.7 K (-1.34 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.84 | 232 | 20,379 | 14,924 | 15.2 K to 14.9 K (-1.53 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.83 | 100 | 8,783 | 15,156 | 15.3 K to 15.2 K (-0.66 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.82 | 100 | 8,782 | 15,256 | 15.4 K to 15.3 K (-0.65 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Sell | S | 87.81 | 500 | 43,905 | 15,356 | 15.9 K to 15.4 K (-3.15 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Buy | M | 70.29 | 3,140 | 220,711 | 15,856 | 12.7 K to 15.9 K (+24.69 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | Kochevar Deborah Turner | Director | Grant | A | 0.00 | 2,436 | 0 | 12,716 | 10.3 K to 12.7 K (+23.70 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Grant | A | 0.00 | 1,034 | 0 | 32,000 | 31 K to 32 K (+3.34 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | MILNE GEORGE M JR | Director | Grant | A | 0.00 | 2,436 | 0 | 30,966 | 28.5 K to 31 K (+8.54 %) |
May 16 2017 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Grant | A | 0.00 | 2,436 | 0 | 28,721 | 26.3 K to 28.7 K (+9.27 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Grant | A | 0.00 | 864 | 0 | 43,704 | 42.8 K to 43.7 K (+2.02 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | REESE C RICHARD | Director | Grant | A | 0.00 | 2,436 | 0 | 42,840 | 40.4 K to 42.8 K (+6.03 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | BERTOLINI ROBERT J | Director | Grant | A | 0.00 | 2,436 | 0 | 22,586 | 20.2 K to 22.6 K (+12.09 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.84 | 130 | 11,549 | 14,701 | 14.8 K to 14.7 K (-0.88 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.78 | 100 | 8,878 | 14,831 | 14.9 K to 14.8 K (-0.67 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.51 | 100 | 8,851 | 14,931 | 15 K to 14.9 K (-0.67 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.50 | 100 | 8,850 | 15,031 | 15.1 K to 15 K (-0.66 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.31 | 100 | 8,831 | 15,131 | 15.2 K to 15.1 K (-0.66 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.28 | 100 | 8,828 | 15,231 | 15.3 K to 15.2 K (-0.65 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.13 | 100 | 8,813 | 15,331 | 15.4 K to 15.3 K (-0.65 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 88.07 | 100 | 8,807 | 15,431 | 15.5 K to 15.4 K (-0.64 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 87.98 | 100 | 8,798 | 15,531 | 15.6 K to 15.5 K (-0.64 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 87.94 | 100 | 8,794 | 15,631 | 15.7 K to 15.6 K (-0.64 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Sell | S | 87.85 | 100 | 8,785 | 15,731 | 15.8 K to 15.7 K (-0.63 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | MASSARO GEORGE | Director | Grant | A | 0.00 | 2,436 | 0 | 15,831 | 13.4 K to 15.8 K (+18.19 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 822 | 0 | 24,248 | 23.4 K to 24.2 K (+3.51 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 2,436 | 0 | 23,426 | 21 K to 23.4 K (+11.61 %) |
May 03 2017 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Option Exercise | A | 90.43 | 1,330 | 120,272 | 1,330 | |
May 03 2017 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Grant | A | 0.00 | 830 | 0 | 830 | 0 to 830 |
May 02 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 89.70 | 237 | 21,259 | 13,258 | 13.5 K to 13.3 K (-1.76 %) |